In vitro activities of N‐acetyl cysteine and levofloxacin as a catheter lock therapy against catheter‐associated infections

摘要

Abstract Aims Since management of catheter‐associated infections, which are generally biofilm‐based, is attempted in certain patients such as older and frail patients by using a catheter lock solution (CLS), we examined the combination of N‐acetyl cysteine (NAC), an antibiofilm agent, and levofloxacin, a broad‐spectrum antimicrobial agent, for this purpose. Methods and Results Intravascular catheters were colonized with methicillin‐resistant Staphylococcus epidermidis, levofloxacin‐sensitive/methicillin‐resistant Staph. aureus, levofloxacin‐resistant/methicillin‐resistant Staph. aureus, vancomycin‐resistant Enterococcus, Escherichia coli, Klebsiella pneumoniae or Pseudomonas aeruginosa and treated with a CLS containing normal saline, NAC, levofloxacin or NAC plus levofloxacin (NACLEV) and then cultured to assess their antimicrobial activities. We also examined antibiofilm and antimicrobial activities of each CLS by scanning electron microscopy (SEM) and the mechanical integrity of catheters exposed to CLS. Treatment of colonized catheters with NACLEV‐CLS significantly reduced colonization (p  0.05). Conclusions These in vitro results suggest that NACLEV‐CLS can significantly reduce all bacterial colonization and potentially help salvage infected catheters without affecting the catheter’s mechanical integrity. Significance and Impact of Study This study presents a novel CLS with a broad spectrum of antimicrobial activity against catheter‐associated infections, particularly in long‐term catheters.